Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Lobaugh SM"" wg kryterium: Autor


Wyświetlanie 1-7 z 7
Tytuł:
A Population-Based Study of Treatment and Survival in Older Glioma Patients.
Autorzy:
Reiner AS; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Lobaugh SM; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Gonen S; Hunter College High School, New York, NY, USA.
Diamond EL; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Panageas KS; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Pokaż więcej
Źródło:
JNCI cancer spectrum [JNCI Cancer Spectr] 2022 Jan 05; Vol. 6 (1).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Astrocytoma*
Glioma*/epidemiology
Oligodendroglioma*/therapy
Aged ; Humans ; Medicare ; Proportional Hazards Models ; United States/epidemiology
Czasopismo naukowe
Tytuł:
Relapse after Allogeneic Stem Cell Transplantation of Acute Myelogenous Leukemia and Myelodysplastic Syndrome and the Importance of Second Cellular Therapy.
Autorzy:
Zuanelli Brambilla C; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medical Biotechnologies, University of Siena, Siena, Italy; Hematology Unit, Department of Oncology, Azienda Ospedaliera Universitaria Senese, Siena, Italy.
Lobaugh SM; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Ruiz JD; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Dahi PB; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Goldberg AD; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Young JW; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York; The Rockefeller University, New York, New York.
Gyurkocza B; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Shaffer BC; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Ponce DM; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Tamari R; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Sanchez Escamilla M; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Hematological Malignancies and Stem Cell Transplantation, Research Institute Marqués de Valdecilla, Santander, Spain.
Castillo Flores N; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Politikos I; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Scordo M; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Shah GL; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Cho C; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Lin RJ; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Maloy MA; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Devlin SM; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Jakubowski AA; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Berman E; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Stein EM; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Papadopoulos EB; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Perales MA; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Tallman MS; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Giralt SA; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Smith M; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York; Cellular Therapeutics Center, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: .
Pokaż więcej
Źródło:
Transplantation and cellular therapy [Transplant Cell Ther] 2021 Sep; Vol. 27 (9), pp. 771.e1-771.e10. Date of Electronic Publication: 2021 May 24.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Hematopoietic Stem Cell Transplantation*
Leukemia, Myeloid, Acute*/therapy
Myelodysplastic Syndromes*/therapy
Humans ; Nucleophosmin ; Recurrence ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Any day, split halfway: Flexibility in scheduling high-dose cisplatin-A large retrospective review from a high-volume cancer center.
Autorzy:
Kang JJ; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Tchekmedyian V; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Mohammed N; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Rybkin A; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Kitpanit S; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Fan M; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Wang H; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Lobaugh SM; Department of Epidemiology-Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Zhang Z; Department of Epidemiology-Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Lee A; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Chen L; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Yu Y; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Zakeri K; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Gelblum DY; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Riaz N; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
McBride SM; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Tsai CJ; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Cohen MA; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Cracchiolo JR; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Morris LG; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Singh B; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Patel S; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Ganly I; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Boyle JO; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Wong RJ; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Eng J; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Zhi WI; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Ng K; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Ho AL; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Dunn LA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Michel L; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Fetten JV; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Pfister DG; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Lee NY; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Sherman EJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Pokaż więcej
Źródło:
International journal of cancer [Int J Cancer] 2021 Jul 01; Vol. 149 (1), pp. 139-148. Date of Electronic Publication: 2021 Feb 27.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Chemoradiotherapy/*mortality
Cisplatin/*therapeutic use
Hospitals, High-Volume/*statistics & numerical data
Neoplasms/*therapy
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents/therapeutic use ; Drug Administration Schedule ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Neoplasms/pathology ; Prognosis ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł:
Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma.
Autorzy:
Lin RJ; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Lobaugh SM; Dept. of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
Pennisi M; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Chan HT; Adult BMT Service, Memorial Sloan Kettering Cancer Center.
Batlevi Y; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Ruiz JD; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Elko TA; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Maloy MA; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Batlevi CL; Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Dahi PB; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Giralt SA; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Hamlin PA; Critical Care Service, Memorial Sloan Kettering Cancer Center, New York, USA.
Mead E; Critical Care Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Noy A; Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Palomba ML; Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York.
Santomasso BD; Neurology Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Sauter CS; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Scordo M; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Shah GL; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Korc-Grodzicki B; Geriatrics Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Kim SJ; Geriatrics Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Silverberg ML; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Brooklyn CA; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Devlin SM; Dept. of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
Perales MA; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Pokaż więcej
Źródło:
Haematologica [Haematologica] 2021 Jan 01; Vol. 106 (1), pp. 255-258. Date of Electronic Publication: 2021 Jan 01.
Typ publikacji:
Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Lymphoma, Large B-Cell, Diffuse*/therapy
Receptors, Chimeric Antigen*/genetics
Aged ; Antigens, CD19 ; Cell- and Tissue-Based Therapy ; Humans ; Immunotherapy, Adoptive ; Receptors, Antigen, T-Cell/genetics
Raport
Tytuł:
The geriatric syndrome of sarcopenia impacts allogeneic hematopoietic cell transplantation outcomes in older lymphoma patients.
Autorzy:
Lin RJ; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Michaud L; Nuclear Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Lobaugh SM; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Nakajima R; Nuclear Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Mauguen A; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Elko TA; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ruiz JD; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Maloy MA; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Sauter CS; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Dahi PB; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Perales MA; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Shah GL; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Castillo Flores N; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Sanchez-Escamilla M; University Hospital and Research Institute of Marqués de Valdecilla (IDIVAL), Santander, Spain.
Tomas AA; Hospital Universitario Puerta de Hierro, Madrid, Spain.
San Segundo LY; University Hospital and Research Institute of Marqués de Valdecilla (IDIVAL), Santander, Spain.
Cho C; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Politikos I; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Kim SJ; Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Korc-Grodzicki B; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.; Geriatrics Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Devlin SM; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Scordo M; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Schöder H; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.; Nuclear Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Giralt SA; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Hamlin PA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.; Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2020 Aug; Vol. 61 (8), pp. 1833-1841. Date of Electronic Publication: 2020 Mar 31.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Hematopoietic Stem Cell Transplantation*/adverse effects
Lymphoma*/complications
Lymphoma*/therapy
Sarcopenia*/complications
Sarcopenia*/diagnosis
Sarcopenia*/epidemiology
Aged ; Humans ; Prospective Studies ; Syndrome ; Transplantation Conditioning
Czasopismo naukowe
Tytuł:
Platinum-based regimens versus cetuximab in definitive chemoradiation for human papillomavirus-unrelated head and neck cancer.
Autorzy:
Beckham TH; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
Barney C; Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH.; Methodist Health System, Omaha, NE.
Healy E; Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH.
Wolfe AR; Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH.
Branstetter A; Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH.
Yaney A; Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH.
Riaz N; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
McBride SM; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
Tsai CJ; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
Kang J; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
Yu Y; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
Chen L; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
Sherman E; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
Dunn L; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
Pfister DG; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
Tan J; Department of Biostatistics, The Ohio State University Wexner Medical Center, Columbus, OH.
Rupert R; Division of Medical Oncology, The Ohio State University Wexner Medical Center, Columbus, OH.
Bonomi M; Division of Medical Oncology, The Ohio State University Wexner Medical Center, Columbus, OH.
Zhang Z; Department of Biostatistics, Memorial Sloan Kettering Cancer Center, Omaha, NE.
Lobaugh SM; Department of Biostatistics, Memorial Sloan Kettering Cancer Center, Omaha, NE.
Grecula JC; Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH.
Mitchell DL; Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH.
Wobb JL; Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH.; Fort Hamilton Hospital, Kettering Medical Center, Hamilton, OH.
Miller ED; Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH.
Blakaj DM; Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH.
Diavolitsis VM; Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH.; Riverside Radiation Oncology, OhioHealth, Columbus, OH.
Lee N; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
Bhatt AD; Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH.; UH Seidman Cancer Center, Case Western Reserve University, Cleveland, OH.
Pokaż więcej
Źródło:
International journal of cancer [Int J Cancer] 2020 Jul 01; Vol. 147 (1), pp. 107-115. Date of Electronic Publication: 2019 Nov 11.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Cetuximab/*therapeutic use
Head and Neck Neoplasms/*drug therapy
Head and Neck Neoplasms/*radiotherapy
Squamous Cell Carcinoma of Head and Neck/*drug therapy
Squamous Cell Carcinoma of Head and Neck/*radiotherapy
Adult ; Aged ; Aged, 80 and over ; Carboplatin/administration & dosage ; Chemoradiotherapy ; Cisplatin/administration & dosage ; Female ; Head and Neck Neoplasms/pathology ; Head and Neck Neoplasms/virology ; Humans ; Male ; Middle Aged ; Neoplasm Staging ; Papillomaviridae ; Papillomavirus Infections/pathology ; Randomized Controlled Trials as Topic ; Squamous Cell Carcinoma of Head and Neck/pathology ; Squamous Cell Carcinoma of Head and Neck/virology ; Survival Rate
Czasopismo naukowe
Tytuł:
Value of [ F]-FDG positron emission tomography in patients with recurrent glioblastoma receiving bevacizumab.
Autorzy:
Graham MS; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; The Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Krebs S; Department of Radiology, Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Bale T; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Domfe K; College of Medicine, SUNY Upstate Medical University, Syracuse, New York, USA.
Lobaugh SM; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Zhang Z; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Dunphy MP; Department of Radiology, Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Kaley T; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; The Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Young RJ; Department of Radiology, Neuroradiology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; The Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Pokaż więcej
Źródło:
Neuro-oncology advances [Neurooncol Adv] 2020 Apr 15; Vol. 2 (1), pp. vdaa050. Date of Electronic Publication: 2020 Apr 15 (Print Publication: 2020).
Typ publikacji:
Journal Article
Czasopismo naukowe
    Wyświetlanie 1-7 z 7

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies